Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod pump is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous ...

Type 2 diabetes means that the body cannot ... The Dexcom monitors and FreeStyle Libre are different than insulin pumps, which can monitor and administer insulin. Medicare also covers some types ...

The Omnipod 5 with the Abbott FreeStyle Libre 2 Plus. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced compatibility between its Omnipod 5 insulin pump and the Abbott (NYSE:ABT) ...

--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology ... with Abbott’s FreeStyle Libre 2 Plus continuous glucose ...

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the ... the global leader in tubeless insulin pump technology with its Omnipod® brand ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is now ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the Omnipod 5 Automated Insulin Delivery (AID) System is ...

Insulet has persuaded a jury that rival South Korean company EOFlow stole trade secrets relating to its wearable insulin pump technology, awarding it a whopping $452 million in damages.

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.